Share on LinkedInShare on LinkedIn

ARTICLE · 14 JULY 2013

Accutane Proposed Class Action Fails To Obtain Certification In Quebec

Claiming to act on behalf of all Quebecers who have developed some form of inflammatory bowel disease as a result of taking the drug Accutane, Mr. Yann Lebrasseur filed a motion seeking certification of a class action.

CanadaLitigation, Mediation & Arbitration

Claiming to act on behalf of all Quebecers who have developed some form of inflammatory bowel disease as a result of taking the drug Accutane, Mr. Yann Lebrasseur filed a motion seeking certification of a class action. However, on June 27, 2013, the Quebec Superior Court refused to allow the action to proceed.

In his motion, Mr. Lebrasseur alleged that he developed Crohn's disease as a result of taking Accutane. He accused the manufacturer, Hoffmann-La Roche Limited, of placing a dangerous product on the market and of failing to properly warn health professionals and consumers about the risks associated with Accutane.

The product monograph prepared by the manufacturer and approved by Health Canada did mention numerous undesirable side effects of the drug, more particularly, the risk of inflammatory bowel disease.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from